Sickle Cell Disease Trial, Recruiting NCT07090668 Sponsor: Emory University Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT07090668
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with sickle-cell anemia (specifically the type called HbSS)
  • Your outer ear has a normal shape and your skin around the ear is healthy and unbroken (this is needed for placing a small device on the ear)
  • You are currently in the hospital because of a pain crisis caused by sickle cell disease
  • You have been hospitalized at least once before for a sickle cell pain crisis

Who may not be able to join:

  • You have a history of seizures
  • You have a psychiatric (mental health) condition that is not well controlled
  • You have repeated episodes where your breathing stops or your heart rate drops very low, and these do not resolve on their own
  • You have a heart muscle disease (called cardiomyopathy)
  • You have been diagnosed with Acute Chest Syndrome (a serious sickle cell complication affecting the lungs)
  • You have a heart or breathing-related birth defect that has not been surgically corrected
  • Your condition is currently making you medically unstable (confirm with trial site)
  • You are pregnant, breastfeeding, or refuse to take a pregnancy test
  • You are a woman who could become pregnant and are not using an adequate form of birth control, or are not willing to use birth control for the duration of the study
  • You have had surgery within the last 3 months
  • You have had a stroke within the last 3 months
  • You currently have a fever, or develop a fever at any point during your hospital stay
  • Your regular medications for sickle cell disease or pain have not yet reached a stable, consistent dose
  • You have been hospitalized 3 or more times for acute pain crises within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna Woodbury, MD, Emory University

Phone: 470-882-8960

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 August 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility: Completion Rate; Stimulation tolerability; Acceptability of intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov